CME Group and Nasdaq Extend Exclusive Nasdaq-100 Futures License Through 2039
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Nasdaq OMX Group Inc. (NDAQ) PT Raised to $99 at Raymond James, 'Firing on All Cylinders'
July 24, 2025 11:30 AM EDTRaymond James analyst Patrick O\'Shaughnessy raised the price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ) to $99.00 (from $96.00) while maintaining a Outperform rating.
The analyst comments "We maintain our Outperform rating on Nasdaq following the release of 2Q25 earnings and increase our... More
Raymond James Reiterates Outperform Rating on Nasdaq OMX Group Inc. (NDAQ)
July 24, 2025 8:13 AM EDTRaymond James analyst Patrick O\'Shaughnessy reiterated an Outperform rating and $96.00 price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ).
The analyst comments "Nasdaq posted strong results in the second quarter with each segment finishing ahead of expectations. Total organic revenue growth of... More
Citi Reiterates Neutral Rating on Nasdaq OMX Group Inc. (NDAQ)
July 24, 2025 8:11 AM EDTCiti analyst Chris Allen reiterated a Neutral rating and $95.00 price target on Nasdaq OMX Group Inc. (NASDAQ: NDAQ).
The analyst comments "NDAQ reported 2Q25 adj. EPS of $0.85 (vs our/Factset consensus est. of $0.83/0.81). Relative to our estimates, net revenue was above our... More
CME Group (CME) PT Raised to $309 at Raymond James
July 23, 2025 12:18 PM EDTRaymond James analyst Patrick O\\\'Shaughnessy raised the price target on CME Group (NASDAQ: CME) to $309.00 (from $306.00) while maintaining a Outperform rating.
The analyst comments "We maintain our Outperform rating on CME Group following 2Q25 earnings and bump our target... More
